Composition and function of AChR chimeric autoantibody receptor T cells for antigen-specific B cell depletion in myasthenia gravis
Oh S, Khani-Habibabadi F, O'Connor K, Payne A. Composition and function of AChR chimeric autoantibody receptor T cells for antigen-specific B cell depletion in myasthenia gravis. Science Advances 2025, 11: eadt0795. PMID: 40020066, PMCID: PMC11870065, DOI: 10.1126/sciadv.adt0795.Peer-Reviewed Original ResearchConceptsChimeric autoantibody receptorsMyasthenia gravisAnti-AChRChimeric autoantibody receptor T cellsSurface expressionSustained surface expressionTarget cell eliminationB-cell depletionT cell cytotoxicityB-cell outgrowthSevere muscle weaknessMouse xenograft modelSuppress immune functionCellular immunotherapyAChR-MGMg therapyT cellsB cellsXenograft modelMuscle weaknessImmune functionNeuromuscular transmissionCell eliminationCD28Gravis
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply